Partnering with Leading Institutions for Healthy Longevity: Prof. Andrea Maier Validates Abinopharm’s Quality Standards

We are honored to share a significant milestone from the 2026 Geromedicine: Unlock Healthy Longevity Conference, hosted by the National University of Singapore (NUS). During the event, Conference Chair Professor Andrea Maier delivered a distinguished introduction for Abinopharm’s CEO, Mr. Lin Yi, spotlighting our strategic collaboration and the vital role of robust scientific validation in the healthy longevity sector.Underscoring our absolute dedication to rigorous quality control, Professor Maier shared her firsthand experience evaluating our premium ingredients, including our flagship AbinoNutra® NMN:"At the NUS Academy for Healthy Longevity, we are conducting numerous clinical trials with his products. Why is that the case? [...] When we brought his products to the lab, they are just superb. That’s the reason why we are doing the trials with Abinopharm." — Professor Andrea Maier, NUS Academy for Healthy LongevityAt Abinopharm, quality is never just a label claim—it is a metric stringently verified by independent laboratory analytics. We are incredibly proud of this prestigious academic validation as we continue to advance our robust human clinical research pipeline alongside world-class institutions like NUS. Together, we remain committed to bringing trusted, scientifically backed longevity solutions to the global market.

To view the full introductory remarks and learn more about our commitment to ingredient excellence, watch the official presentation video here: Watch the Conference Video on YouTube